These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 16384971

  • 1. Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection.
    McClellan SA, Huang X, Barrett RP, Lighvani S, Zhang Y, Richiert D, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):256-64. PubMed ID: 16384971
    [Abstract] [Full Text] [Related]

  • 2. Regulation of Pseudomonas aeruginosa corneal infection in IL-1 beta converting enzyme (ICE, caspase-1) deficient mice.
    Thakur A, Barrett RP, McClellan S, Hazlett LD.
    Curr Eye Res; 2004 Jan; 29(4-5):225-33. PubMed ID: 15590467
    [Abstract] [Full Text] [Related]

  • 3. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis.
    Huang X, Du W, McClellan SA, Barrett RP, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4910-6. PubMed ID: 17065506
    [Abstract] [Full Text] [Related]

  • 4. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
    Hazlett LD, McClellan SA, Barrett RP, Liu J, Zhang Y, Lighvani S.
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480
    [Abstract] [Full Text] [Related]

  • 5. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated.
    McClellan SA, Zhang Y, Barrett RP, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1502-11. PubMed ID: 18385069
    [Abstract] [Full Text] [Related]

  • 6. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis.
    Huang X, Barrett RP, McClellan SA, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4209-16. PubMed ID: 16249500
    [Abstract] [Full Text] [Related]

  • 7. ST2 is essential for Th2 responsiveness and resistance to pseudomonas aeruginosa keratitis.
    Huang X, Du W, Barrett RP, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4626-33. PubMed ID: 17898286
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of nitric oxide in resistance to P. aeruginosa ocular infection.
    Hazlett LD, McClellan S, Goshgarian C, Huang X, Thakur A, Barrett R.
    Ocul Immunol Inflamm; 2005 Oct; 13(4):279-88. PubMed ID: 16159718
    [Abstract] [Full Text] [Related]

  • 12. Corneal response to Pseudomonas aeruginosa infection.
    Hazlett LD.
    Prog Retin Eye Res; 2004 Jan; 23(1):1-30. PubMed ID: 14766315
    [Abstract] [Full Text] [Related]

  • 13. Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection.
    Hazlett LD, Rudner XL, McClellan SA, Barrett RP, Lighvani S.
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):419-24. PubMed ID: 11818386
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
    Hazlett LD, McClellan S, Kwon B, Barrett R.
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Testican-1 promotes resistance against Pseudomonas aeruginosa-induced keratitis through regulation of MMP-2 expression and activation.
    Berger EA, McClellan SA, Barrett RP, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2011 Jul 18; 52(8):5339-46. PubMed ID: 21613368
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.